Hill's Pet Nutrition, Inc.

Colgate Palmolive Company

Ab Mauri Food Inc., D/b/a Ohly Americas

Dennis Edward Jewell

Matthew Jackson

Dale Allen Fritsch

Jeffrey Brockman

Kiran Panickar

William David Schoenherr

Steven Curtis Zicker

Dale S Scherl

Eden Ephraim

Jennifer Macleay

Kathy L Gross

Luis Montelongo

Jodi Vondran

Bruce Caterson

Christopher Bond Little

John Leander Harwood

John Francis Innes

Inke Paetau-Robinson

Hungwei Lin

Mark Lee Dierking

Chadwick Everett Dodd

Geoff Bednar

Fernando Qvyjt

Christina Golder

Naina Kiran Shah

Timothy Vande Giessen

Stephen Davidson

Christopher Waldy

Albert Avila

William D Schoenherr

Kim Gene Friesen

Christina Khoo

Karen Joy Wedekind

Claudia A Kirk

Neil P Stout

Philip William Toll

Jack K Lin

Eden Ephraim Gebreselassie

Yanrong Liu

Charles F Lin

Philip W Toll

Timothy Glen Vande Giessen

Cheryl C Miller

Laura Morgan

Larry R Prewitt

Melissa Vanchina

Luis Jose Montelongo

Larry H Hayward

Jeffrey A Brockman

Blair Ogleby

Dale Scott Scherl

Luis José Montelongo

Karen Wedekind

Dale Scherl

Luis J Montelongo

Kevin A Hahn

David Goshaw

Eden Ephraim Gebresalassie

Jason Lindecrantz

Disclosed herein are pet food compositions for treating or preventing—inter alia—struvite urolithiasis comprising at N least one of caprylic acid and capric acid; and at least one of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis

Pet food compositions and methods for increasing body weight and decreasing indoles in a feline having renal insufficiency are provided. The methods may include feeding the feline an effective amount of the pet food composition. The pet food composition may include fermentable fibers and betaine.

Pet food compositions and methods for the same

The current invention relates to animal food kibbles having a primarily disc shape and including botanicals such as curcumin. The current invention also relates to methods to reduce oral inflammation in an animal by feeding the animal with the food kibbles. The disc-shaped food kibbles induce a reduction of oral inflammation in the animal compared to control food kibbles having a different shape.

Composition and method for reducing or treating oral inflammation

Disclosed herein is a pet food composition and methods of making a pet food composition using an extrusion process, wherein the resultant pet food composition comprises an enhanced level of resistant starch. The pet food compositions disclosed herein may increase the proportions of beneficial gastrointestinal bacteria, such asand, while decreasing deleterious bacteria such as. The improved microbial environment resulting from the pet food compositions disclosed herein having an enhanced level of resistant starch may lead to both improved gastrointestinal and psychobiotic health for the animal consuming the pet food composition.

Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch

The present disclosure is directed to a method for reducing immunoreactivity of a food including (a) incubating a food that contains at least one protein with a cross-linking enzyme to form a food that includes at least one cross-linked protein; and (b) fermenting the food including the at least one cross-linked protein with a microorganism to form a modified food including a hydrolysate of the at least one cross-linked protein, wherein (a) is performed before (b) and wherein a level of immunoreactivity of the modified food is less than a level of immunoreactivity of an unmodified food including at least one protein. Modified foods obtained from the present method are also provided.

Method and compositions for reducing immunorecognition of dietary protein

Methods of identifying canine subjects having an increased likelihood of developing elevated levels of 4-ethylphenyl sulfate, canine stress, canine anxiety and/or an inhibition of growth of beneficial microbes and promotion of growth of harmful microbes are disclosed. Methods comprise analyzing a biological sample obtained from the canine subject for the presence of two copies of a minor allele of the single nucleotide polymorphism BICF2P1175095 in a canine subject. Methods of treating the identified canine subjects by administering an effective amount of tomato pomace are also disclosed. Methods of treating canine subjects for elevated 4-EPS levels, canine anxiety or canine stress are disclosed. Canine food compositions that comprises tomato pomace are disclosed.

Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate in canines and identifying canines at risk of such conditions

Methods of analyzing a biological sample obtained from the canine subject for the presence of one or two copies one or two copies of minor allele T of SNP Affx-206229307; or one or two copies of minor allele A of SNP Affx-206560187; or one or two copies of minor allele T of SNP Affx-206229307 and one or two copies of minor allele A of SNP Affx-206560187 are disclosed. The methods are used in methods to identify a canine subject that has an increased likelihood or risk of hypothyroidism and in methods of treating a canine subject to reduce risk of hypothyroidism or to treat a canine subject that has hypothyroidism. The treatments comprise administering to the canine subject a low arginine diet and/or comprising an effective amount of a composition comprising a protein source, a carbohydrate source, a vegetable source, and a fruit source. Canine food compositions are disclosed.

Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions

Compositions and methods of treating anxiety or stress in an animal are disclosed. Compositions and methods of reducing or preventing elevated levels of 4-EPS are disclosed. Compositions and methods for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes are disclosed. The methods comprise administering to the animal an effective amount of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber. Compositions comprise effective amounts of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber.

Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate

The invention provides dry pet food diet compositions that include visible micronutrient particles comprising micronutrients, and improved methods for their preparation. The methods provide pet food diet compositions that have improved palatability and retention of micronutrients.

Pet food with visible particles and process for making same

Compositions and methods are disclosed for treating anxiety or stress in an animal, for reducing elevated levels of 4-EPS in an animal with elevated 4-EPS levels, for preventing elevated levels of 4-EPS in an animal and for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes. The methods comprise administering to the animal an effective amount of soy protein and vitamin C. Compositions are disclosed which comprise amounts of soy protein and vitamin C effective for use in the methods.

Described herein are kits for assessing the calcium oxalate titration test of an animal as well as methods for predicting the risk of calcium oxalate stone formation. Further described herein are methods and compositions for&#x2014;inter alia&#x2014;lowering the specific gravity of urine and lowering the calcium oxalate titration test in felines. In particular, diets and methods utilizing certain amounts and ratios of arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are disclosed herein.

Calcium oxalate titration test kits and pet food compositions

Described herein are pet food compositions comprising: a beta glucan; and a pentacyclic triterpene; wherein the weight ratio of the beta glucan to the pentacyclic triterpene, is about 1:1. Methods of making and using these compositions are also described.

Pet food compositions

A food composition for managing non-food allergies in companion animals is disclosed, along with a method of managing non-food allergies.

Pet food composition for managing non-food allergies

Described herein are pet food compositions comprising aextract obtained from the tissue of a tea which is greater than about 40% oxidized; and a fiber component, wherein theextract and the fiber component are present in an amount effective to provide, after about 24 hours post-ingestion, a fecal hydrogen sulfide concentration of less than 450 mg/L, and a colonic lumen pH of less than 5.0. Methods of making and using these pet food compositions are also described.

The present invention relates to compositions that enhances the palatability of pet foods designed for companion animals, e.g. dogs and cats, with renal insufficiency, and for methods of their manufacture.

Palatability enhancers for foods designed for dogs and cats with renal insufficiency

Growing community of inventors

Topeka, KS, United States of America

Dennis Edward Jewell